Eliminating Epidemic Group A Meningococcal Meningitis in Africa Through a New Vaccine
This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in 2010. Widespread use of the vaccine throughout much of Africa may prevent more than a million cases of meningitis over the next decade. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): LaForce FM, Okwo-Bele J-M
Visit web page (English)
(Located at content.healthaffairs.org)
Citation: LaForce FM, Okwo-Bele J-M. Eliminating Epidemic Group A Meningococcal Meningitis in Africa Through a New Vaccine. Health Affairs. 2011;30(6):1049-1057.